In this episode, Dr. Shanda Blackmon, Executive Director of the Baylor College of Medicine Lung Institute, and Dr. Sunjay Devarajan explore bronchiectasis, a chronic and heterogeneous lung condition that often represents a common endpoint for many underlying diseases. They discuss how the disease develops, its varied clinical presentations, and the importance of identifying and treating underlying causes such as rheumatoid arthritis. 

The conversation highlights treatment strategies including airway clearance therapy, considerations for surgical intervention, and emerging approaches that target inflammation. The episode also examines promising research into pure anti–neutrophil elastase treatments and their potential role in the future of bronchiectasis care.

Baylor College of Medicine Lung Institute (713)798-LUNG